This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Toshihiko Maruta, PhD
Mayo Clinic and Mayo Foundation Rochester, MN 55905

Arch Gen Psychiatry. 1982;39(10):1217-1218.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—During the past several years, there has been an increasing interest in the clinical use of the dexamethasone suppression test (DST). Although the ultimate clinical value of the DST is far from clear information pointing to to its potential clinical application has been accumulating rapidly. In particular, the article by Carroll and associates¹ has further increased this interest. With the added publicity of the mass media, it is not unusual for psychiatrists in large institutions to receive telephone calls from outside psychiatrists and non-psychiatric physicians asking for procedures and interpretations of the DST. From that experience, I wish to make several statements of caution in regard to the clinical application of DST.

1. As far as can be ascertained, what Carroll et al called "plasma cortisol" concentration, measured by competitive protein-binding assay,² is in reality plasma . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?